Authors

Accelerating Personalization

How is AI solving pharma's speed-to-market challenge?

Transforming Supply Chains into Quality Systems for Advanced Therapies

In this Dedicated Dialogue episode, Adam Fox, Chief Quality & Regulatory Affairs Officer of Cryoport Systems, explores how escalating regulatory expectations and patient-centric risk considerations are reshaping how advanced therapy supply chains are designed and scaled. Fox examines the quality infrastructure and end-to-end control strategies required to protect high‑value, temperature-controlled materials in an era where regulatory expectations and patient impact are higher than ever.

Navigating Access and Reimbursement Through Uncertainty

A forum intended for HCPs, policy experts, and industry leaders addresses pressing obstacles facing this sector of the industry today.

Patent Cliff Pressures to Drive Big Pharma M&A

In the final part of his Pharma Commerce video interview, Dan Chancellor, Norstella’s vice president of thought leadership, shares that companies facing the largest revenue gaps from looming patent expirations—including Bristol Myers Squibb—could be poised for increased dealmaking as they look to rebuild growth pipelines.

Monitoring Payer-Level Performance and Planning

Payer-level reporting should do more than track performance—it must guide strategy, focus resources, and drive measurable brand impact.

Revolutionizing Patient Care: The Top Five Benefits of Investing in Innovation

Monitoring Payer-Level Performance and Planning

Payer-level reporting should do more than track performance—it must guide strategy, focus resources, and drive measurable brand impact.

Pharma’s US Manufacturing Push Faces a Long Investment Horizon

In the final part of his Pharma Commerce video interview, Franco Stevanato, CEO of Stevanato Group, explains that with plant buildouts and validation requiring three to five years, today’s reshoring momentum reflects near-term policy pressures, but global demand and overseas biosimilar growth will ultimately shape the industry’s next phase.

Uniting for Patients: Helping More Americans Navigate, Access and Afford Health Care

Keys to Advancing HCP Engagement

Why meaningful content must meet the right audience.

Caught Beneath the Surface: The Hidden Potential of Patient Data

Filling the gaps in the patient journey within an increasingly complex data environment.

Bridging People, Process, and Technology

How can 360° connectivity drive pharma innovation?

How AI Ecosystems Could Transform Pharma Demand and Crisis Response

In the final part of his Pharma Commerce video interview, Joe Hudicka, entrepreneur and supply chain expert, outlines how real-time AI signal sharing across supply chain partners can help pharma companies anticipate demand shifts, reduce shortages, and respond faster to pandemics and geopolitical disruptions.

Building Durability in Rare Disease Care With PANTHERx Rare

Bansi Nagji discusses the shifting science behind rare and orphan drug development, including what it takes for therapies to succeed well beyond launch.

WISeR Spending or Unneeded Delays in Healthcare? Prior Authorizations, AI in Medicare Prompt Concerns

The new Medicare payment model aims to take down wasteful spending, but Congress and analysts point out potential problems.

Protecting Temperature-Sensitive Pharmaceuticals, Without Unnecessary Plastic Waste

Advances in the life sciences are driving a significant increase in the number of temperature-sensitive pharmaceuticals. The packaging industry is meeting the moment with advances of its own, including high-performance, environmentally-friendly materials that allow life science companies meet stringent thermal requirements and ambitious CO2e reduction goals. In this episode, TemperPack’s CEO Peter Wells shares insights from working with life sciences to move to certified biobased, home compostable, and curbside recyclable shipping solutions.

The Role of CDMOs in the Pharma Cold Chain Machine

Exploring the importance of contract development and manufacturing organizations in advancing the latest technology for effective delivery of temperature-sensitive medicines.

The Unwritten Requirement for CNPVs

In the third part of his Pharma Commerce video interview, Brad Stewart, BDO’s national life sciences co-leader, explains that while the FDA has not defined the specific level of manufacturing commitment needed to improve US supply chain resilience, applicants for the voucher should focus on linking unique or rare disease therapies—particularly in areas like oncology—with domestic onshoring efforts to move their applications to the top of the pile for selection.

A Complex Chess Game With Invisible Chess Pieces

Ed Schoonveld examines the uncertainty surrounding President Trump's MFN drug pricing agreements, stalled GENEROUS, GLOBE and GUARD proposals, and their ripple effects on ex-US drug launches.

Sonicu serves scores of hospital-based, specialty and retail pharmacies with our simple and affordable temperature and environmental monitoring

Learn how easy and affordable it can be to adopt a wireless remote temperature and environmental monitoring system that can protect your vital temperature-sensitive assets while automating tedious compliance

Your Hub Strategy Is Our Strategy: Patient Support Programs That Adapt, Scale, and Deliver

Sydni Johnston, Associate Director at Cardinal Health Sonexus™ Access and Patient Support, explains how manufacturers can build more stable and scalable patient support programs by adopting a flexible approach that aligns hub models with specific organizational goals.

Precision Dosing as a Market Strategy: How Model-Informed Tools Drive Cost, Speed and Access

By reducing waste, improving forecasting, and strengthening payer negotiations, these technologies are helping pharmaceutical companies unlock efficiency, accelerate adoption, and differentiate in competitive markets.

Beyond Awareness: Modeling Shared Decision-Making in Patient Communications

When patients struggle to see a positive path forward, modeling a constructive journey can give them the confidence they need.

Serialization 2.0: Why It’s Time to Upgrade, and What’s at Stake

This serialization system represents a business imperative that yields significant competitive advantages.

Designing Patient Hubs Purpose-Built for Cell and Gene Therapies

These hubs can streamline access, reduce friction across reimbursement and logistics, and improve outcomes, as the CGT pipeline expands and patient demand accelerates.

Smart Packaging in Pharma: Driving Adherence and Safety Through Digital Innovation

These innovations are revolutionizing pharmaceutical packaging by enhancing drug safety, combating counterfeiting, ensuring regulatory compliance, and improving patient adherence across the supply chain.

The Changing Role of Access Leaders

Modernizing the Last Mile

In the final part of his Pharma Commerce video interview, Arthur Axelrad, co-founder and CEO of Dispatch Science, explains how outdated, batch-based communication between shippers and carriers is undermining last-mile resilience—and why APIs, cloud platforms, and real-time connectivity are essential to improving transparency, safety, and speed in healthcare logistics.

Why CX Is a Difference Maker for Pharma

Direct-to-consumer and direct-to-patient models are major contributors.